Innova Captab
add_icon

Innova Captab

707.65
+0.55
(0.08%)
Market Cap
4,049.52 Cr
PE Ratio
30.58
Volume
13,736.00
Day High - Low
709.10 - 694.00
52W High-Low
1,024.00 - 624.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
4,049.52 Cr
EPS
22.41
PE Ratio
30.58
PB Ratio
3.97
Book Value
148.31
EBITDA
198.20
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
13.37
Debt to Equity
0.33
Analyst Rating and Forecast
- By Refinitiv from2 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
positive
Innova Captab Limited announces interim dividend of ₹2 per share (20% of face value) for FY 2025-26 with record date January 30, 2026. Company issues TDS guidelines for shareholders.
positive
Innova Captab Limited reported consolidated revenue of ₹4,519.47 million for Q3 FY26, up from ₹3,207.87 million in Q3 FY25, with net profit after tax reaching ₹421.49 million.
neutral
Innova Captab Limited has scheduled a board meeting for January 23, 2026, to consider Q3FY26 unaudited financial results and potential interim dividend declaration with record date set for January 30, 2026.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,695.10
#1 4,06,711.27
37.29
#1 54,729.00
9.71
#1 10,980
16.07
53.41
6,024.50
1,59,931.55
65.55
9,712.00
18.67
2,191
35.10
42.74
3,939.00
1,33,313.66
62.83
11,539.40
6.99
1,911
30.46
48.76
1,330.00
1,07,433.65
23.75
28,409.50
7.12
5,291
-57.18
31.68
1,241.20
1,03,594.32
18.82
33,741.20
16.73
5,725
-15.28
54.90
2,173.70
99,294.36
23.31
22,909.50
13.74
3,306
#1 72.75
54.01
888.15
89,368.67
#1 18.11
23,511.00
18.55
4,615
34.60
45.46
2,060.20
85,046.10
47.68
12,744.20
#1 20.90
2,007
7.65
41.28
1,191.00
69,173.47
20.08
32,345.60
9.43
3,484
3.81
52.17
5,684.00
67,960.75
28.09
13,458.30
3.70
2,216
10.98
50.40

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
14.80 %
Net Income Growth
36.06 %
Cash Flow Change
-56.38 %
ROE
17.80 %
ROCE
-1.26 %
EBITDA Margin (Avg.)
3.41 %

Quarterly Financial Results

Quarterly Financials
Mar 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
217
244
245
244
234
286
305
268
296
320
321
318
356
385
452
Expenses
197
211
208
214
202
243
258
225
252
269
270
267
299
329
381
EBITDA
21
33
37
29
32
44
47
44
44
52
51
51
57
56
71
Operating Profit %
9 %
13 %
14 %
11 %
13 %
14 %
15 %
15 %
14 %
16 %
15 %
15 %
15 %
14 %
15 %
Depreciation
3
3
3
3
3
5
5
3
5
5
5
10
11
11
11
Interest
3
5
6
5
5
9
7
1
0
0
0
2
3
6
4
Profit Before Tax
15
25
28
21
25
30
35
40
39
47
46
39
43
39
56
Tax
2
6
9
4
7
7
10
11
10
12
11
10
12
10
14
Net Profit
13
19
20
17
18
23
25
29
30
35
34
30
31
30
42
EPS in ₹
108.91
3.91
4.08
3.59
3.67
4.77
4.39
5.02
5.15
6.12
5.97
5.17
5.42
5.18
7.37

Balance Sheet

Balance Sheet
2019
2020
2021
2022
2023
2024
2025
Total Assets
0
245
370
576
704
1,321
1,580
Fixed Assets
0
73
79
183
183
358
830
Current Assets
0
171
271
379
443
580
696
Capital Work in Progress
0
0
7
0
22
341
23
Investments
0
0
0
0
0
0
0
Other Assets
0
172
283
392
500
622
728
Total Liabilities
0
245
370
576
704
1,321
1,580
Current Liabilities
0
120
215
295
278
266
353
Non Current Liabilities
0
14
10
72
150
225
268
Total Equity
0
110
145
209
277
831
959
Reserve & Surplus
0
98
133
197
229
774
902
Share Capital
0
12
12
12
48
57
57

Cash Flow

Cash Flow
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
1
2
3
-5
3
8
4
Investing Activities
-9
-6
-20
-188
-91
-499
-152
Operating Activities
19
31
42
59
67
146
64
Financing Activities
-9
-23
-19
125
27
361
92

Share Holding

% Holding
Jun 2022
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
69.75 %
50.90 %
50.90 %
50.90 %
50.90 %
50.90 %
50.90 %
50.90 %
50.90 %
50.90 %
50.90 %
FIIs
0.00 %
0.00 %
0.00 %
1.94 %
1.19 %
1.01 %
0.74 %
0.34 %
0.23 %
0.08 %
0.11 %
DIIs
0.00 %
11.73 %
4.98 %
20.77 %
21.23 %
20.61 %
19.96 %
19.76 %
19.67 %
20.17 %
20.24 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
32.10 %
32.29 %
25.47 %
25.80 %
26.00 %
26.96 %
27.62 %
27.71 %
27.35 %
27.22 %
Others
30.25 %
5.26 %
11.83 %
0.91 %
0.88 %
1.48 %
1.45 %
1.37 %
1.49 %
1.50 %
1.53 %
No of Share Holders
7
1,39,154
1,39,154
39,396
35,115
32,254
36,692
39,996
41,014
40,245
38,691

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
18 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
18 Sept 2024 692.15 803.70
07 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Nov 2024 741.45 842.70
05 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
05 Feb 2025 895.70 1,008.00
19 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
19 May 2025 844.75 923.15
31 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
31 Jul 2025 844.30 918.80
07 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Aug 2025 900.00 927.05
07 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Nov 2025 815.80 801.50
23 Jan 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 Jan 2026 679.35 654.20
30 Jan 2026 DIVIDEND Dividend
₹ 2.00 /share
30 Jan 2026 654.20 677.30

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation4 days ago
Announcement under Regulation 30 (LODR)-Earnings Call Transcript4 days ago
Announcement under Regulation 30 (LODR)-Earnings Call Transcript4 days ago
Communication To The Shareholders Of The Company Regarding Deduction Of Tax At Source (TDS) On Interim Dividend Declared For FY 2025-26.10 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome10 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 24, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationJan 23, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 23, 2026
Outcome Of The Board Meeting Held Today I.E. 23Rd January 2026Jan 23, 2026
The Company Has Fixed Record Date For The Interim Dividend.Jan 23, 2026
Corporate Action-Board approves DividendJan 23, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held Today 23Rd January 2026Jan 23, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 19, 2026
Corporate Action-Board to consider DividendJan 19, 2026
Board Meeting Intimation for Intimation Of Board MeetingJan 16, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2026
Closure of Trading WindowDec 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 10, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 15, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 10, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 08, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 07, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 07, 2025
Approval Of The Unaudited (Standalone And Consolidated) Financial Results For The Quarter And Half Year Ended 30Th September 2025.Nov 07, 2025
Mr. Devendra Ganpatrav Palav Who Currently Serves As The Chief Executive Officer (CEO) Of Sharon Bio-Medicine Limited A Material Subsidiary Of The Company Has Been Redesignated As Manager In Addition To His Existing Role As CEO.Nov 07, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. 07Th November 2025Nov 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 03, 2025
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (LODR)Regulations 2015 For Consideration Of Unaudited (Standalone And Consolidated) Financial Results For The Quarter And Half Year Ended 30Th September 2025.Oct 30, 2025
Recommendation Of GMP Compliance Certificate By The State Service Of Ukraine On Medicines And Drugs Control.Oct 20, 2025
Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.Oct 16, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 07, 2025
Closure of Trading WindowSep 26, 2025
Pursuant To Regulation 30 Read With Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) We Hereby Inform You That M/S. CARE Ratings Limited A Credit Rating Agency Has Revised The CreSep 16, 2025
Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (The Listing Regulations).Aug 21, 2025
Pursuant To The Regulation 30 (Read With Part A Of Schedule III) And Other Applicable Provisions Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations) We Hereby Inform That The Company Has Successfully Completed Aug 20, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 08, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 08, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 07, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 07, 2025
Outcome Of The Board Meeting Held Today I.E. 07Th August 2025Aug 07, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. 07Th August 2025Aug 07, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 31, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMJul 31, 2025
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For Consideration Of Unaudited (Standalone And Consolidated) Financial Results For The Quarter EndJul 30, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportJul 25, 2025
Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations 2011Jul 09, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 07, 2025

Technical Indicators

RSI(14)
Neutral
52.64
ATR(14)
Less Volatile
33.18
STOCH(9,6)
Neutral
55.43
STOCH RSI(14)
Overbought
88.84
MACD(12,26)
Bullish
5.81
ADX(14)
Strong Trend
34.57
UO(9)
Bearish
46.94
ROC(12)
Uptrend And Accelerating
8.33
WillR(14)
Neutral
-41.04